RxDoctor Payments Data

Amina Husain, MD

Ophthalmology · Olympia Fields, ILNPI 1841494416

Payments from drug & device makers

$711in general payments, 2019–2025

Across 19 payments — averaging $37.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$125
  • Amgen$119
  • AbbVie$119
  • Sun Pharmaceutical Industries Inc.$118
  • Sanofi$105
  • Merck$87
  • plus $38 from 1 others

What the payments were for

  • Food & beverage$63289%
  • Education$8011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alcon3$125
Amgen1$119
AbbVie(2 entities)5$119
Sun Pharmaceutical Industries Inc.1$118
Sanofi1$105
Merck6$87
Otsuka America Pharmaceutical, Inc.2$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$711 in reported general payments places this provider in the 40th percentile of 773 ophthalmology providers in Illinois.

See all ophthalmology providers in Illinois

Medicare billing

Part B allowed, 2024
$29,254
Medicare patients
145
Services billed
608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErythromycinErythromycin Base81$1,052
Latanoprost47$490
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat27$362
Timolol Maleate13$116

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Olympia Fields

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →